UY37498A - Una sal maleato de la base libre de n-[5-(aminosulfonil)-4-20 metil-1,3-tiazol-2-il]-n-metil-2-[4-(2-piridinil)-fenil]-acetamida, formulaciones farmacéuticas, métodos de fabricación y usos de la misma - Google Patents
Una sal maleato de la base libre de n-[5-(aminosulfonil)-4-20 metil-1,3-tiazol-2-il]-n-metil-2-[4-(2-piridinil)-fenil]-acetamida, formulaciones farmacéuticas, métodos de fabricación y usos de la mismaInfo
- Publication number
- UY37498A UY37498A UY0001037498A UY37498A UY37498A UY 37498 A UY37498 A UY 37498A UY 0001037498 A UY0001037498 A UY 0001037498A UY 37498 A UY37498 A UY 37498A UY 37498 A UY37498 A UY 37498A
- Authority
- UY
- Uruguay
- Prior art keywords
- methyl
- pharmaceutical formulations
- acetamide
- aminosulfonil
- piridinyl
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Virology (AREA)
- Dermatology (AREA)
- Communicable Diseases (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
La presente invención se refiere al campo de los agentes antivirales activos, particularmente a sales, más particularmente a una sal maleato de la base libre de N-[5-(aminosulfonil)-4-metil-1,3-tiazol-2-il]-N-metil-2-[4-(2-piridinil)-fenil]-acetamida, a sus formulaciones farmacéuticas así como a métodos para la producción de estas sales. La presente invención también se refiere al uso de estas sales y de sus formulaciones farmacéuticas respectivas en métodos de tratamiento y/o prevención de infecciones con el virus herpes simple humano, particularmente infecciones causadas por HSV-1 y HSV-2.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP16201009 | 2016-11-28 |
Publications (1)
Publication Number | Publication Date |
---|---|
UY37498A true UY37498A (es) | 2018-06-29 |
Family
ID=57421722
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
UY0001037498A UY37498A (es) | 2016-11-28 | 2017-11-28 | Una sal maleato de la base libre de n-[5-(aminosulfonil)-4-20 metil-1,3-tiazol-2-il]-n-metil-2-[4-(2-piridinil)-fenil]-acetamida, formulaciones farmacéuticas, métodos de fabricación y usos de la misma |
Country Status (14)
Country | Link |
---|---|
US (2) | US11266636B2 (es) |
EP (2) | EP3892620A1 (es) |
JP (2) | JP7316214B2 (es) |
CN (3) | CN117186085A (es) |
AR (1) | AR110251A1 (es) |
AU (4) | AU2017365639B2 (es) |
CA (1) | CA3045063A1 (es) |
ES (1) | ES2877854T3 (es) |
HU (1) | HUE054845T2 (es) |
PL (1) | PL3544977T3 (es) |
PT (1) | PT3544977T (es) |
TW (3) | TWI753972B (es) |
UY (1) | UY37498A (es) |
WO (1) | WO2018096177A1 (es) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2573085A1 (en) | 2011-09-26 | 2013-03-27 | AiCuris GmbH & Co. KG | N-[5-(aminosulfonyl)-4methyl-1,3-thiazol-2-yl]-N-methyl-2-[4-(2-pyridinyl)phenyl] acetamide mesylate monohydrate having a specific particle size distribution range and a specific surface area range |
AR110249A1 (es) * | 2016-11-28 | 2019-03-13 | Aicuris Anti Infective Cures Gmbh | Hemihidrato de la base libre de n-[5-(aminosulfonil)-4-metil-1,3-tiazol-2-il]-n-metil-2-[4-(2-piridinil)-fenil]-acetamida, métodos de fabricación y usos del mismo |
CN117186085A (zh) * | 2016-11-28 | 2023-12-08 | 艾库里斯有限及两合公司 | 普瑞利韦硫酸盐、其药物制剂、制造方法及治疗疱疹病毒的用途 |
WO2019068817A1 (en) | 2017-10-05 | 2019-04-11 | Innovative Molecules Gmbh | SUBSTITUTED THIAZOLEAN ENANTIOMERS AS ANTIVIRAL COMPOUNDS |
TW202038947A (zh) | 2018-11-28 | 2020-11-01 | 德商創新分子有限責任公司 | 在與溶瘤病毒之組合療法中治療癌症的解旋酶引子酶抑制劑 |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6944877B1 (en) * | 1999-08-27 | 2005-09-13 | Koninklijke Philips Electronics N.V. | Closed loop addressable advertising system and method of operation |
DOP2000000109A (es) * | 1999-12-23 | 2002-08-30 | Gerald Kleymann | Derivados de tiazolilamida |
DE10129714A1 (de) | 2001-06-22 | 2003-01-02 | Bayer Ag | Topische Anwendung von Thiazolylamiden |
DE102005014248A1 (de) * | 2005-03-30 | 2006-10-05 | Aicuris Gmbh & Co. Kg | Pharmazeutische Zubereitung von N-[5-(Aminosulfonyl)-4-methyl-1,3-thiazol-2-yl]-N-methyl-2-[4-(2-pyridinyl)phenyl]acetamid |
WO2008004796A1 (en) * | 2006-07-03 | 2008-01-10 | Sk Chemicals Co., Ltd. | Salts of pyrrolopyrimidinone derivatives and process for preparing the same |
WO2011115173A1 (ja) * | 2010-03-18 | 2011-09-22 | 興和株式会社 | ベンゾチアジン化合物のモノマレイン酸塩 |
EP2598502B1 (en) | 2011-09-26 | 2014-05-14 | AiCuris GmbH & Co. KG | N-[5-(aminosulfonyl)-4-methyl-1,3-thiazol-2-yl]-n-methyl-2-[4-(2-pyridinyl)phenyl]acetamide mesylate monohydrate having a specific particle size distribution range and a specific surface area range for use in pharmaceutical formulations. |
EP2573086A1 (en) | 2011-09-26 | 2013-03-27 | AiCuris GmbH & Co. KG | N-[5-(Aminosulfonyl)-4-methyl-1,3-thiazol-2-yl]-N-methyl-2-[4-(2-pyridinyl)phenyl]acetamide mesylate monohydrate |
EP2573085A1 (en) | 2011-09-26 | 2013-03-27 | AiCuris GmbH & Co. KG | N-[5-(aminosulfonyl)-4methyl-1,3-thiazol-2-yl]-N-methyl-2-[4-(2-pyridinyl)phenyl] acetamide mesylate monohydrate having a specific particle size distribution range and a specific surface area range |
SG11201506153TA (en) * | 2013-02-12 | 2015-09-29 | Aicuris Gmbh & Co Kg | Helicase-primase inhibitors for use in a method of treating alzheimer's disease |
AR110249A1 (es) * | 2016-11-28 | 2019-03-13 | Aicuris Anti Infective Cures Gmbh | Hemihidrato de la base libre de n-[5-(aminosulfonil)-4-metil-1,3-tiazol-2-il]-n-metil-2-[4-(2-piridinil)-fenil]-acetamida, métodos de fabricación y usos del mismo |
CN117186085A (zh) * | 2016-11-28 | 2023-12-08 | 艾库里斯有限及两合公司 | 普瑞利韦硫酸盐、其药物制剂、制造方法及治疗疱疹病毒的用途 |
-
2017
- 2017-11-28 CN CN202311025223.9A patent/CN117186085A/zh active Pending
- 2017-11-28 TW TW106141398A patent/TWI753972B/zh active
- 2017-11-28 EP EP21174191.3A patent/EP3892620A1/en active Pending
- 2017-11-28 TW TW112121637A patent/TW202413354A/zh unknown
- 2017-11-28 PT PT178165445T patent/PT3544977T/pt unknown
- 2017-11-28 EP EP17816544.5A patent/EP3544977B1/en active Active
- 2017-11-28 ES ES17816544T patent/ES2877854T3/es active Active
- 2017-11-28 WO PCT/EP2017/080695 patent/WO2018096177A1/en active Application Filing
- 2017-11-28 TW TW111100053A patent/TWI808591B/zh active
- 2017-11-28 AR ARP170103304A patent/AR110251A1/es unknown
- 2017-11-28 CN CN201780073159.8A patent/CN110062755B/zh active Active
- 2017-11-28 CA CA3045063A patent/CA3045063A1/en active Pending
- 2017-11-28 US US16/464,189 patent/US11266636B2/en active Active
- 2017-11-28 UY UY0001037498A patent/UY37498A/es unknown
- 2017-11-28 AU AU2017365639A patent/AU2017365639B2/en active Active
- 2017-11-28 CN CN202311023094.XA patent/CN117186084A/zh active Pending
- 2017-11-28 HU HUE17816544A patent/HUE054845T2/hu unknown
- 2017-11-28 PL PL17816544T patent/PL3544977T3/pl unknown
- 2017-11-28 JP JP2019528126A patent/JP7316214B2/ja active Active
-
2021
- 2021-05-10 AU AU2021202942A patent/AU2021202942B2/en active Active
-
2022
- 2022-01-21 AU AU2022200409A patent/AU2022200409B2/en active Active
- 2022-01-26 US US17/585,145 patent/US20220152009A1/en active Pending
- 2022-07-14 JP JP2022113134A patent/JP2022145700A/ja active Pending
-
2023
- 2023-02-13 AU AU2023200773A patent/AU2023200773B2/en active Active
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
UY37498A (es) | Una sal maleato de la base libre de n-[5-(aminosulfonil)-4-20 metil-1,3-tiazol-2-il]-n-metil-2-[4-(2-piridinil)-fenil]-acetamida, formulaciones farmacéuticas, métodos de fabricación y usos de la misma | |
CL2018003291A1 (es) | Amidas heterocíclicas útiles como moduladores de proteínas (divisional de solicitud cl 2850-2018). | |
UY37496A (es) | Hemihidrato de la base libre de n-[5-(aminosulfonil)-4-metil-1,3-tiazol-2-il]-n-metil-2-[4-(2-piridinil)-fenil]-acetamida, métodos de fabricación y usos del mismo | |
CL2020000122A1 (es) | Métodos de tratamiento para la fibrosis quística. | |
CL2017000469A1 (es) | Derivados de tetrahidronaftaleno que inhiben la proteina mcl-1 | |
CO2018004857A2 (es) | Derivados de dihidroimidazopirazinona usados en el tratamiento del cáncer | |
BR112015020118A2 (pt) | derivados de 2-aminopirimidina para o tratamento de infecções virais | |
BR112015011036A2 (pt) | derivados de 2-amino-quinazolina substituídos heterocíclicos para o tratamento de infecções virais | |
CL2015001916A1 (es) | Derivados de pirimidona y su uso en el tratamiento, mejora o prevención de una enfermedad viral. | |
CR20160036A (es) | Inhibidores cristalinos de bromodominios | |
CL2015002361A1 (es) | Inhibidores quinazolínicos de formas mutadas activantes del receptor del factor de crecimiento epidérmico | |
UY35586A (es) | Derivados de la pirazolopirrolidina y su uso en el tratamiento de enfermedades | |
CU24525B1 (es) | Derivado de quinoleína para tratar y prevenir infecciones virales | |
AR103680A1 (es) | Inhibidores selectivos de bace1 | |
CL2014000149A1 (es) | Metodo para sintetizar n-[5-(aminosulfonil)-4-metil-1,3-tiazol-2-il]-n-metil-2-[4-(2-piridinil) fenil)]acetamida y mesilato monohidrato cristalino del mismo; composicion farmaceutica que lo contiene; combinacion farmaceutica; uso en el tratamiento y/o profilaxis de una infeccion por virus herpes simplex. | |
DOP2014000081A (es) | Compuestos y procedimientos para mejorar las respuestas inmunitarias innatas | |
CL2016001756A1 (es) | Preparación farmacéutica que comprende 0,001-0,003 pv de 6-4-pirazol-1-ilbencilpiridin-3-ilsulfonilaminometilpiridin-2-ilaminoacetato de isopropilo o una sal del mismo uso para el tratamiento o prevención de glaucoma o hipertensión ocular. | |
CL2017001001A1 (es) | Derivados de carbazaol | |
CL2019002900A1 (es) | Análogos de benzoazepina como agentes inhibidores de la tirosina cinasa de bruton. | |
UY35455A (es) | Inhibidores tripeptidicos de la epoxicetona proteasa | |
CL2018002811A1 (es) | Derivados de aminotiazol útiles como agentes antivíricos. | |
CL2017000845A1 (es) | Inhibidores de gingipaina de lisina | |
UY36145A (es) | Compuestos de 1, 3, 4-tiadiazol y uso de los mismos para el tratamiento del cáncer | |
UY38228A (es) | Compuestos de triazolopirimidina y su uso en el tratamiento del cáncer | |
DOP2016000297A (es) | Composiciones farmacéuticas útiles para tratar enfermedades infecciosas |